Literature DB >> 3520611

Meal patterns of rats with dorsomedial hypothalamic nuclei lesions or sham operations.

L L Bellinger, V E Mendel, L L Bernardis, T W Castonguay.   

Abstract

Rats with bilateral dorsomedial hypothalamic electrolytic lesions (DMNL rats) are hypophagic, hypodipsic and have reduced linear and ponderal growth when compared to sham operated controls (SCON). Nevertheless, previous studies have shown that DMNL rats eat and drink adequate amounts for their size and have normal body composition. In the present study we investigated meal parameters: meal size, and frequency (both light and dark period), total intake and meal size per metabolic size (body weight 0.75). Compared to SCON, DMNL rats at twelve days post surgery weighed less, were shorter, but had a normal body composition as determined by the Lee Index, and were hypophagic (grams eaten/day). The animals were placed into individual, self-contained feeding modules and given powdered chow. After familiarization to the modules, meal parameters were recorded continuously by a computer for an eight day period. While dark phase meal frequency did not differ significantly between groups, the lesioned rats took more meals during the light period. Over the eight-day measurement period DMNL rats were hypophagic compared to SCON in absolute terms. However, when total intake and meal size were normalized to metabolic size, these two parameters did not differ significantly between groups. Upon refeeding, after a one-day fast, the initial meal size of the normally hypophagic DMNL rats exceeded that of SCON. Rats with DMNL have previously been shown to have deficits in some hypothesized short-term food intake control mechanism (e.g., cholecystokinin, glucose sensing). Thus overeating by the lesioned rats after a fast could possibly result from a specific short term control deficit.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3520611     DOI: 10.1016/0031-9384(86)90356-2

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice.

Authors:  Shin J Lee; Saurabh Verma; Stephanie E Simonds; Melissa A Kirigiti; Paul Kievit; Sarah R Lindsley; Alberto Loche; M Susan Smith; Michael A Cowley; Kevin L Grove
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

2.  Failure to demonstrate disruption of ultradian growth hormone rhythm and insulin secretion by dorsomedial hypothalamic nucleus lesions that cause reduced body weight, linear growth and food intake.

Authors:  L L Bernardis; G S Tannenbaum
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

3.  Nicotine's attenuation of body weight involves the perifornical hypothalamus.

Authors:  Phillip R Kramer; Guoqiang Guan; Paul J Wellman; Larry L Bellinger
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

4.  Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance.

Authors:  Liang Yang; Karen A Scott; Jayson Hyun; Kellie L Tamashiro; Nancy Tray; Timothy H Moran; Sheng Bi
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

5.  Efferent projections of neuropeptide Y-expressing neurons of the dorsomedial hypothalamus in chronic hyperphagic models.

Authors:  Shin J Lee; Melissa Kirigiti; Sarah R Lindsley; Alberto Loche; Christopher J Madden; Shaun F Morrison; M Susan Smith; Kevin L Grove
Journal:  J Comp Neurol       Date:  2013-06-01       Impact factor: 3.215

Review 6.  Functional organization of neuronal and humoral signals regulating feeding behavior.

Authors:  Gary J Schwartz; Lori M Zeltser
Journal:  Annu Rev Nutr       Date:  2013-04-29       Impact factor: 11.848

Review 7.  Dorsomedial hypothalamic NPY and energy balance control.

Authors:  Sheng Bi; Yonwook J Kim; Fenping Zheng
Journal:  Neuropeptides       Date:  2012-10-18       Impact factor: 3.286

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.